Paid Clinical Trials Eugene

Discover 145 paid clinical trials in Eugene, Oregon. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 145

Rinatabart SesutecanRinatabart Sesutecan (Rina-S) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Recruiting

PHASE1

PHASE2

Sponsor:

Genmab

Location:

Eugene OR, Portland OR, Santa Rosa CA, West Valley City UTshow 26 more

Code:

NCT05579366

Conditions

Platinum-Resistant Ovarian Cancer

Platinum Sensitive Ovarian Cancer (PSOC)

High Grade Epithelial Ovarian Cancer

High Grade Serous Ovarian Cancer

Primary Peritoneal Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Rina-S

Carboplatin

Bevacizumab

Pembrolizumab

IbrutinibA Study to Customize Ibrutinib Treatment Regimens for Participants With Previously Untreated Chronic Lymphocytic Leukemia

Recruiting

PHASE2

Sponsor:

Janssen Research & Development, LLC

Location:

Eugene OR, Portland OR, Vancouver WA, Seattle WAshow 29 more

Code:

NCT05963074

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell

Small Lymphocytic Lymphoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Ibrutinib

Venetoclax

Budesonide, Glycopyrronium, FormoterolA Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

Recruiting

PHASE3

Sponsor:

AstraZeneca

Location:

Roseburg OR, Grants Pass OR, Medford OR, Boise IDshow 196 more

Code:

NCT06283966

Conditions

COPD (Chronic Obstructive Pulmonary Disease)

Eligibility Criteria

Sex: All

Age: 40 - 70+

Healthy Volunteers: Not accepted

Interventions

BGF MDI 320/14.4/9.6 μg

GFF MDI 14.4/9.6 μg

Immunotherapy with ChemotherapyTesting the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-Small Cell Lung Cancer, ALCHEMIST Trial

Recruiting

PHASE3

Sponsor:

National Cancer Institute (NCI)

Location:

Corvallis OR, Coos Bay OR, Newberg OR, Bend ORshow 740 more

Code:

NCT04267848

Conditions

Lung Non-Small Cell Carcinoma

Lung Non-Small Cell Squamous Carcinoma

Lung Non-Squamous Non-Small Cell Carcinoma

Stage II Lung Cancer AJCC v8

Stage IIIA Lung Cancer AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Carboplatin

Cisplatin

Computed Tomography

Echocardiography Test

BI 1584862A Study to Test Different Doses of BI 1584862 in People With a Distinct Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy

Recruiting

PHASE2

Sponsor:

Boehringer Ingelheim

Location:

Eugene OR, Portland OR, Sacramento CA, Walnut Creek CAshow 16 more

Code:

NCT06769048

Conditions

Geographic Atrophy

Eligibility Criteria

Sex: All

Age: 55+

Healthy Volunteers: Not accepted

Interventions

Placebo-matching BI 1584862

BI 1584862

BI 771716A Study to Test Whether BI 771716 Helps People With an Advanced Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy

Recruiting

PHASE2

Sponsor:

Boehringer Ingelheim

Location:

Eugene OR, Spokane WA, Sacramento CA, Walnut Creek CAshow 42 more

Code:

NCT06722157

Conditions

Macular Degeneration, Age-related

Geographic Atrophy

Eligibility Criteria

Sex: All

Age: 50+

Healthy Volunteers: Not accepted

Interventions

BI 771716

Pegcetacoplan

Sham comparator to BI 771716

Luveltamab Tazevibulin vs. IC ChemotherapyREFRaME-O1: A Study to Investigate the Efficacy and Safety of Luveltamab Tazevibulin Versus Investigator's Choice (IC) Chemotherapy in Women With Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers) Expressing FOLR1

Recruiting

PHASE2

PHASE3

Sponsor:

Sutro Biopharma, Inc.

Location:

Eugene OR, Portland OR, Daly City CA, Tucson AZshow 22 more

Code:

NCT05870748

Conditions

Ovarian Cancer

Epithelial Ovarian Cancer

Fallopian Tube Cancer

Primary Peritoneal Cancer

Platinum-resistant Ovarian Cancer

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Luveltamab tazevibulin

Pegfilgrastim

Gemcitabine

Paclitaxel

Pegylated liposomal doxorubicin

AzeliragonStudy of Effect of Azeliragon in Patients Refractory to Prior Treatment of Metastatic Pancreatic Cancer

Recruiting

PHASE1

PHASE2

Sponsor:

Cantex Pharmaceuticals

Location:

Eugene OR, Los Angeles CA, Tyler TX, Pittsburgh PAshow 2 more

Code:

NCT05766748

Conditions

Metastatic Pancreatic Cancer

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Azeliragon

Cema-celConsolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

Recruiting

PHASE2

Sponsor:

Allogene Therapeutics

Location:

Eugene OR, Portland OR, Seattle WA, Sacramento CAshow 33 more

Code:

NCT06500273

Conditions

Large B-cell Lymphoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

cemacabtagene ansegedleucel

ALLO-647

Fludarabine

Cyclophosphamide

Foresight CLARITY™ IUO MRD test, powered by PhasED-Seq™

Baxdrostat & DapagliflozinA Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin on CKD Progression in Participants With CKD and High Blood Pressure.

Recruiting

PHASE3

Sponsor:

AstraZeneca

Location:

Roseburg OR, Surrey, Vancouver, Lincoln CAshow 126 more

Code:

NCT06268873

Conditions

Chronic Kidney Disease and Hypertension

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Baxdrostat/dapagliflozin

Dapagliflozin in combination with placebo